Global and United States Propofol Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States Propofol Market Report & Forecast 2024-2034
The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.
Market Analysis and InsightsGlobal and United States Propofol Market
This report focuses on global and United States Propofol market, also covers the segmentation data of other regions in regional level and county level.
The global Propofol revenue was US$ 18 million in 2024 and is forecast to a readjusted size of US$ 22 million by 2034 with a CAGR of 3.6% during the forecast period (2024-2034).
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Global Propofol Scope and Market Size
Propofol market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Propofol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Propofol market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.

Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Propofol definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Propofol companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Propofol in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Market Analysis and InsightsGlobal and United States Propofol Market
This report focuses on global and United States Propofol market, also covers the segmentation data of other regions in regional level and county level.
The global Propofol revenue was US$ 18 million in 2024 and is forecast to a readjusted size of US$ 22 million by 2034 with a CAGR of 3.6% during the forecast period (2024-2034).
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Global Propofol Scope and Market Size
Propofol market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Propofol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Propofol market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.

By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Propofol definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Propofol companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Propofol in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
